Experimental drug APN01 prevents COVID-19 infection in the lab – News-Medical.Net

With the world gripped with the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a frantic rush to find an effective drug that can be used to treat the disease. Researchers from the University of British Columbia, in collaboration with others, have found an experimental drug that can inhibit the SARS-CoV-2 virus from infecting host cells. Their study titled, "Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2," was published in the latest issue of the journal Cell.

Read more
Celularity and Infectious Disease Research Institute will try out COVID-19 cell therapy – GeekWire

Celularitys subsidiary, LifebankUSA, maintains a repository of placental and cord blood, containing stem cells for potential therapeutic use. (LifebankUSA / Robert Hariri via Twitter) Seattles Infectious Disease Research Institute and a New Jersey company called Celularity have been cleared by the Food and Drug Administration to start trials of an experimental cell-based therapy for COVID-19

Read more
Orgenesis partners with Belgium"s RevaTis to develop stem cells for therapeutic use – Proactive Investors USA & Canada

The two firms plan to leverage Orgenesiss autologous Cell and Gene Therapy Biotech Platform to produce muscle-derived mesenchymal stem cells (mdMSC) as a source of exosomes Inc () is teaming up with regenerative medicine and cell therapy firm RevaTis on a new joint venture to produce certain stem cells for therapeutic use, it said Wednesday.

Read more
India Based Stem Cell Research Firm To Test Its Stem Cell Product For Acute Respiratory Disease Syndrome (ARDS) COVID-19 – IndianWeb2.com

Stempeutics Research, a group company of Manipal Education and Medical Group (MEMG), announced today that it has partnered with Global Consortium of cell therapy companies seeking European Commission Funding to Fight Against Corona! (FAC!). Under this partnership, Stempeutics will export its stem cell product Stempeucel (subject to regulatory approvals) for treating critically ill COVID-19 patients with lung disease

Read more
Key Provisions of the Legislature’s Internal Rules – The Joint Rules Part I – California Globe

Beyond the relevant provisions of the California Constitution (contained primarily in Article IV), as well as applicable sections of the California Government Code, the State Senate and State Assembly are governed by their Joint Rules, the Standing Rules of the Senate and the Standing Rules of the Assembly. This article provides a summary of the Joint Rules of the Senate and Assembly.

Read more
COVID-19 Impact on Stem Cell Banking Identify Which Types of Companies Could Potentially Benefit or Loose out From the Impact of COVID-19 – Science…

Complete study of the global Stem Cell Banking market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Stem Cell Banking industry.

Read more
Understanding the Canadian Institutions of Health Research and Institute of Nutrition, Metabolism and Diabetes – Open Access Government

The Institute of Nutrition, Metabolism and Diabetes (INMD) is a branch of the Canadian Institutes of Health Research (CIHR). The CIHR Canadas federal funding for health research1, who collaborate with partners and researchers to find solutions that improve the healthcare system of Canada. This article concerns how, and if, the CIHR continuing to support excellence in health research is still their top priority, this will be done with a focus on the INMD.

Read more